Showing 7 of 27 recruiting trials for “Primary myelofibrosis”
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
👨⚕️ Rachel B. Salit, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Feb 2021View details ↗
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
👨⚕️ Maria Cancio, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Nov 2020View details ↗
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
RecruitingNCT02934477 ↗
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
RecruitingNCT02760238 ↗
Myeloproliferative Neoplasms (MPNs) Patient Registry
RecruitingNCT01973881 ↗
Quantitative MRI for Myelofibrosis
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →